In the press

Richard Williams comments on the Prologis offer for SEGRO

Biotech trusts top performance charts in February

Richard Williams comments on the offer for SEGRO in Robin Amos’ article:

“SEGRO’s potential has arguably improved with a latent large data centre development pipeline. The argument now is whether it has the balance sheet capacity to build out this pipeline quickly enough to extract superior returns.”

Read the article here